# N-Acetylcysteine in Heart Failure With Coexistent Chronic Renal Failure

> **NCT00532688** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Bayside Health** · enrollment: 10 (estimated)

## Conditions studied

- Heart Failure, Congestive
- Kidney Failure, Chronic

## Interventions

- **DRUG:** N-acetylcysteine

## Key facts

- **NCT ID:** NCT00532688
- **Lead sponsor:** Bayside Health
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-09
- **Primary completion:** —
- **Final completion:** 2008-02
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2007-09-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00532688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00532688, "N-Acetylcysteine in Heart Failure With Coexistent Chronic Renal Failure". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00532688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*